4//SEC Filing
Aeglea BioTherapeutics, Inc. 4
Accession 0001140361-16-066304
$SYRECIK 0001636282operating
Filed
May 18, 8:00 PM ET
Accepted
May 19, 4:37 PM ET
Size
5.6 KB
Accession
0001140361-16-066304
Insider Transaction Report
Form 4
Rojas-Caro Sandra
Chief Medical Officer
Transactions
- Award
Employee Stock Option
2016-05-17+200,000→ 200,000 totalExercise: $7.28Exp: 2026-05-16→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable as to 1/4th of the shares subject to the option on May 17, 2017, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.
Documents
Issuer
Aeglea BioTherapeutics, Inc.
CIK 0001636282
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001636282
Filing Metadata
- Form type
- 4
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 4:37 PM ET
- Size
- 5.6 KB